Note: This section contains information in English only.On Monday, Biogen announced it would acquire Nightstar Therapeutics in the $800M worth cash-deal, amid company's intention to expand its footprint in the gene therapy market.
Mon, 04 Mar 2019 09:36:44 GMT
Source: Dukascopy Bank SA